Clinical Trial Update: Adjunctive Celecoxib in Childhood-onset OCD Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adjunctive celecoxib for pediatric obsessive-compulsive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder
• Psychiatric Disorder

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: University of British Columbia | Conditions: Obsessive-Compulsive Disorder, Pediatric Psychiatric Disorder | Phase 2 | Status: UNKNOWN